ACAD logo

ACADIA Pharmaceuticals (ACAD) Accounts Receivable

Annual Accounts Receivable

$98.27 M
+$36.07 M+58.00%

December 31, 2023


Summary


Performance

ACAD Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Quarterly Accounts Receivable

$98.21 M
-$5.49 M-5.29%

September 30, 2024


Summary


Performance

ACAD Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

ACAD Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+58.0%+5.8%
3 y3 years+103.7%+61.8%
5 y5 years+276.6%+218.8%

ACAD Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+58.0%-5.3%+76.2%
5 y5-yearat high+174.6%-5.3%+174.5%
alltimeall timeat high-100.0%-5.3%-100.0%

ACADIA Pharmaceuticals Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$98.21 M(-5.3%)
Jun 2024
-
$103.70 M(+9.5%)
Mar 2024
-
$94.70 M(-3.6%)
Dec 2023
$98.27 M(+58.0%)
$98.27 M(+5.9%)
Sep 2023
-
$92.80 M(+13.4%)
Jun 2023
-
$81.85 M(+24.2%)
Mar 2023
-
$65.92 M(+6.0%)
Dec 2022
$62.20 M(-3.4%)
$62.20 M(+11.6%)
Sep 2022
-
$55.73 M(-18.0%)
Jun 2022
-
$67.95 M(+8.4%)
Mar 2022
-
$62.71 M(-2.6%)
Dec 2021
$64.37 M(+33.4%)
$64.37 M(+6.0%)
Sep 2021
-
$60.70 M(+18.2%)
Jun 2021
-
$51.37 M(-9.6%)
Mar 2021
-
$56.83 M(+17.8%)
Dec 2020
$48.25 M
$48.25 M(+4.1%)
Sep 2020
-
$46.34 M(+5.8%)
Jun 2020
-
$43.78 M(+5.2%)
DateAnnualQuarterly
Mar 2020
-
$41.64 M(+16.4%)
Dec 2019
$35.78 M(+37.1%)
$35.78 M(+16.2%)
Sep 2019
-
$30.80 M(-3.1%)
Jun 2019
-
$31.78 M(+6.1%)
Mar 2019
-
$29.96 M(+14.8%)
Dec 2018
$26.09 M(+50.4%)
$26.09 M(+30.7%)
Sep 2018
-
$19.96 M(-22.3%)
Jun 2018
-
$25.70 M(+14.5%)
Mar 2018
-
$22.45 M(+29.4%)
Dec 2017
$17.34 M(+193.8%)
$17.34 M(+22.0%)
Sep 2017
-
$14.22 M(+22.7%)
Jun 2017
-
$11.59 M(+51.4%)
Mar 2017
-
$7.66 M(+29.8%)
Dec 2016
$5.90 M(>+9900.0%)
$5.90 M(+53.8%)
Sep 2016
-
$3.84 M(+1210.2%)
Jun 2016
-
$293.00 K(>+9900.0%)
Dec 2015
$0.00
$0.00(-100.0%)
Sep 2010
-
$1.93 M(-34.0%)
Jun 2010
-
$2.93 M

FAQ

  • What is ACADIA Pharmaceuticals annual accounts receivable?
  • What is the all time high annual accounts receivable for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual accounts receivable year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly accounts receivable year-on-year change?

What is ACADIA Pharmaceuticals annual accounts receivable?

The current annual accounts receivable of ACAD is $98.27 M

What is the all time high annual accounts receivable for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual accounts receivable is $98.27 M

What is ACADIA Pharmaceuticals annual accounts receivable year-on-year change?

Over the past year, ACAD annual accounts receivable has changed by +$36.07 M (+58.00%)

What is ACADIA Pharmaceuticals quarterly accounts receivable?

The current quarterly accounts receivable of ACAD is $98.21 M

What is the all time high quarterly accounts receivable for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly accounts receivable is $103.70 M

What is ACADIA Pharmaceuticals quarterly accounts receivable year-on-year change?

Over the past year, ACAD quarterly accounts receivable has changed by +$5.41 M (+5.83%)